Tirzepatide 5 mg is a GLP-1 and GIP dual receptor agonist designed to help regulate blood glucose levels and support metabolic health. It mimics the action of natural hormones that stimulate insulin secretion, reduce glucagon production, and slow gastric emptying, leading to better glycemic control and reduced appetite.
This medication is commonly prescribed for type 2 diabetes management and weight reduction in overweight or obese adults. By controlling blood sugar and appetite, Tirzepatide 5 mg can enhance overall metabolic health and aid in long-term diabetes management strategies.
Key Benefits:
-
Improves blood sugar control in type 2 diabetes
-
Supports healthy weight loss and appetite reduction
-
Enhances insulin secretion and glucose metabolism
-
Reduces post-meal glucose spikes
-
Clinically proven GLP-1/GIP receptor agonist
Dosage & Administration:
Administer Tirzepatide 5 mg via subcutaneous injection once weekly, as prescribed by a healthcare provider. Dosage adjustments may be made based on response and tolerance.
Precautions:
Use only under medical supervision. Not suitable for individuals with a history of medullary thyroid carcinoma, pancreatitis, or hypersensitivity to Tirzepatide. Store in a refrigerator and protect from light.











Reviews
There are no reviews yet.